Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis.

Mathieu, Clément; Bezin, Julien; Pariente, Antoine

Mathieu, Clément; Bezin, Julien; Pariente, Antoine.

Afiliación

Mathieu C; Inserm, Bordeaux Population Health Research Center, Team AHeaD, UMR 1219, University Bordeaux, Bordeaux, France.
Bezin J; Inserm, Bordeaux Population Health Research Center, Team AHeaD, UMR 1219, University Bordeaux, Bordeaux, France.
Pariente A; CHU de Bordeaux, Service de Pharmacologie Médicale, Bordeaux, France.

Front Pharmacol ; 14: 1129244, 2023.

Article en En | MEDLINE | ID: mdl-37256233

Palabras clave

COVID-19; antihypertensive drug; cardiovascular drugs; impact assessment; interrupted time series; pharmacoepidemiology; treatment disruption

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google